Announcing the 2026 Hall of Fame Philadelphia Titan 100 Honorees
Globe Newswire • Thu Jun 11 2026
Titan CEO and headline sponsor Cherry Bekaert are pleased to announce Dea Belazi, CEO and co-founder, as a 2026 Philadelphia Titan 100 Hall of Fame honoree.
BERWYN, Pa., June 11, 2026 (GLOBE NEWSWIRE) – Titan CEO and headline sponsor Cherry Bekaert are pleased to announce Dea Belazi, CEO and co-founder, AscellaHealth, a global partner delivering customizable solutions for the specialty pharmaceutical industry, as a 2026 Philadelphia Titan 100 Hall of Fame honoree.
The Titan 100 recognizes Philadelphia’s Top 100 CEOs and C-level executives, the region’s most accomplished leaders who have not only built extraordinary companies but have redefined what it means to lead. These Titans exemplify excellence through their vision, passion and integrity, creating lasting impact across industries and communities.
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.